| http://www.w3.org/ns/prov#value | - Side effects, such as fluid retention and heart weight gain associated with PPARgamma full agonists, were diminished with 51 in comparison to rosiglitazone based on studies in two independent animal models. (PMID: 22070604)Categorized Comment - additional comments and annotationsHelptop of pageFrom BioAssay Depositor:Assay Type: BindingTarget Type: T
|
